Today's Healthcare Pulse
Allogene Therapeutics CEO David Chang to step down
Allogene Therapeutics announced that chief executive David Chang will leave his role. The news was reported by STAT+ and echoed in a follow‑up piece covering broader pharma updates.
Also developing:
By the numbers: Boston Scientific invests $1.5B for 34% stake in MiRus
5 Keys to Enhancing Automation, Expanding Capacity and Improving Efficiency to Reduce Costs
Healthcare providers face tighter margins, staffing shortages and complex payer rules in 2026, prompting a move away from reactive revenue‑cycle models. Organizations are adopting intelligent automation that targets front‑end functions such as eligibility, authorization and financial clearance, using AI‑driven decision support to prevent errors before they occur. Digital tools are reshaping the patient financial experience, delivering real‑time estimates and automated outreach that improve payment rates and reduce missed appointments. Predictive RCM, strategic technology partnerships and disciplined governance are now seen as essential to scale efficiency without adding cost.
Regulating Private Equity in Health Care: A Strategic Policy Agenda
Private equity has poured roughly $1 trillion into U.S. health‑care assets over the past ten years, reshaping nursing homes, hospitals, and physician groups. Existing oversight—anchored in the Hart‑Scott‑Rodino reporting framework and limited antitrust actions—has struggled to keep pace, with more than...
Health IT Leaders Eye AI, Data Sharing to Improve Affordability
Health IT leaders, convened by the Health IT Advisory Committee, highlighted data interoperability, streamlined prior authorization, and transparent AI as levers to lower healthcare costs. ONC National Coordinator Thomas Keane underscored affordability as a top priority alongside liquidity and technology evolution....
In Britain, a New Law Targeting a Beloved Vice Would Shock Americans. I Surprised Myself With My Reaction.
Britain has passed a landmark law that bars anyone born after 2008 from ever purchasing cigarettes, with the ban slated to begin on Jan. 1, 2027. The measure, championed by Health Minister Baroness Merron, follows years of incremental tobacco restrictions and mirrors...
Nationwide Screenings Uncover Early Signs of Hypertension in Children
Indonesia’s government health‑check programme screened 4.8 million schoolchildren across 48,000 schools between Jan 1 and May 3, 2026. About 22.1 percent – roughly 663,000 students – recorded blood‑pressure readings above normal for their age, signaling early signs of hypertension. Officials said the findings warrant...
Critical Care Documentation: Why It’s Different and How It Impacts Patient Care
Critical care transport demands exhaustive documentation, capturing minute‑by‑minute ventilator settings, medication doses, lab results, and advanced interventions. Errors or omissions can jeopardize patient safety, expose providers to liability, and undermine agency reimbursement. The article argues that clunky, manual charting drains...
Researchers Develop Body-Compatible Dermal Electrode
Researchers at POSTECH have created a dermal bioelectrode that inserts like a microneedle but becomes soft in the dermis, eliminating immune response. The electrode’s effervescent sacrificial layer enables rapid penetration and then transforms to a flexible structure, delivering stable biosignal...
Ocrelizumab Preserves Ambulation, Hand Function in MS
A six‑year analysis of the ENSEMBLE trial shows that early‑stage relapsing‑remitting multiple sclerosis patients treated with ocrelizumab largely maintained functional ability. 86.1% preserved normal ambulation and 93% kept normal hand dexterity throughout the study, while 34% of those with baseline...
Listen Closer: What Triage Nurses Hear That Others Miss
Telehealth triage nurses rely on a clinical sixth‑sense honed in emergency departments, letting them read subtle vocal cues that signal serious illness or distress. The article shows how this intuition outperforms pure call‑throughput metrics by preventing emergencies and offering critical...
Braveheart Bio's Hengrui-Licensed Cardiac Drug Scores Second Clinical Win
Braveheart Bio announced that its heart‑muscle therapy, licensed from China’s Jiangsu Hengrui Pharmaceuticals, achieved its primary endpoint in a mid‑stage (Phase 2) trial for heart failure with reduced ejection fraction. The study reported an 8% absolute improvement in left‑ventricular ejection fraction...
MAiD and Mental Illness: Canada's Unfinished Debate
Canada’s Medical Assistance in Dying (MAiD) law broadened in 2021 with Bill C‑7, creating two tracks that now allow individuals whose sole suffering is a mental disorder to request assisted death. The framework mandates two independent assessors, a written request,...
Digital Maturity Sets the Foundation for AI-Powered Care
Health systems are accelerating digital transformation to build robust data backbones that support seamless interoperability and strong governance. By standardizing data exchange, they create a foundation for AI-driven tools that can personalize patient interactions. Alexandra Wright of HIMSS highlights that...
Drug Repurposing
The FDA has issued a request for public comment on drug repurposing, seeking input from patients, clinicians, and researchers on priority disease areas and candidate drugs. The initiative builds on existing programs such as Project Renewal, which updates oncology drug...
Late Line RCC: Where Darlifarnib Fits and Why LITESPARK-012 Matters
At the International Kidney Cancer Symposium, Kura presented phase 1 data showing its next‑generation farnesyl transferase inhibitor darlifarnib combined with cabozantinib achieved a 44% objective response rate in clear cell renal cell carcinoma patients previously treated with cabozantinib. The cohort was...
FDA Embraces AI: Radiology Leads 1,400 Approvals via 510(k)
The FDA, a global leader in healthcare regulation, is adapting its framework to include AI-based medical devices, with 1400 approvals and clearances to date, indicating an acknowledgment of AI’s expanding role in healthcare. Radiology leads in AI device approvals reflecting deep...
South Western Sydney Unveils Enhanced Mental Health and Suicide Prevention Plan to 2030
South Western Sydney Primary Health Network and South Western Sydney Local Health District launched an upgraded regional mental health and suicide prevention plan, targeting improved access, integration and culturally responsive services through 2030. The initiative builds on a previous plan...
Aspen Psychedelic Symposium Showcases Natural Medicine’s Healing Promise
The Aspen Psychedelic Resource Center, Healing Advocacy Fund and Aspen Public Radio are hosting the 2026 Aspen Psychedelic Symposium June 6‑7 at the Wheeler Opera House. The two‑day event brings together researchers, clinicians and spiritual practitioners to examine how psychedelic...
Protesters Demand Direct Helicopter Access to Seattle Children’s Hospital
Protesters gathered near Seattle Children’s Hospital demanding that all pediatric emergency helicopters be permitted to land directly on the campus. Currently, a 1990s‑era policy limits landings to only “critically ill or injured” children, forcing 73 of 222 airlifts in 2025...
Fractyl Secures Dutch CTA for First GLP‑1 Gene Therapy Trial
Fractyl Health today announced that it has received Clinical Trial Application (CTA) authorization in the Netherlands to initiate the Phase 1/2 first-in-human study of RJVA-001 - $GUTS first clinical candidate from its Rejuva 🧵👇 GLP-1 Gene Therapy platform and the...
Canvys Expands 4K Display Platform for Medical Applications with New 32-Inch Monitor
Canvys, a division of Richardson Electronics, announced a new 32‑inch 4K monitor that extends its existing medical‑grade display platform. The Ultra HD screen offers 3840 × 2160 resolution, high color accuracy, and a True Flat, non‑reflective surface designed for easy cleaning. Built...
Noncovalent Fragments vs WRN
Researchers at Merck and Proteros reported a noncovalent fragment‑based campaign against the Werner syndrome helicase (WRN), a synthetic‑lethal cancer target. Using a 1,020‑compound fluorine‑fragment library screened by 19F‑NMR and a separate 500‑compound SPR screen, they identified seven primary hits, three...
Sunscreen: How to Help Protect Your Skin From the Sun
The FDA is tightening sunscreen oversight, revisiting rules first proposed in 2019 and formally updated in 2021 under the CARES Act. The agency emphasizes broad‑spectrum SPF 15+ products, proper application, and re‑application every two hours. It also warns against using sunscreen...
Newsweek AI Impact Awards 2026 Highlight HealthTech Breakthroughs
Newsweek’s second‑annual AI Impact Awards recognized 52 AI firms, including a slate of health‑care innovators, at a ceremony in San Francisco. The winners reflect a surge in AI adoption—50% of U.S. workers now use AI tools—and raise questions about data...
STAT+: Pharmalittle: We’re Reading About Medicare and Alzheimer’s Drugs, Estrogen Patch Shortages, and More
Medicare enrollment in the newly approved Alzheimer’s therapies Leqembi and Kisunla is dramatically lower than the federal government expected. The agency now projects minimal spending on the drugs through 2027, a sharp reversal from earlier forecasts of billions in annual...
Kansas Veterans Hit by Oracle‑Cerner EHR Rollout, $33 B VA Cost Overruns
Oracle’s management of the Department of Veterans Affairs’ $10 billion electronic health record contract, inherited from its 2022 $28.4 billion acquisition of Cerner, has led to cost estimates exceeding $33 billion and service disruptions for Kansas veterans. The fallout includes more than 500...
Avalere Health Expands to Japan
Avalere Health announced the launch of a new office in Tokyo, marking its first dedicated presence in Japan. The office will provide end‑to‑end consulting for Japanese biopharmaceutical companies across oncology, diabetes, immunology and rare‑disease product lifecycles. Led by former McCann...
Massachusetts Commission Calls for Statewide Action on Rising Xylazine Contamination
The Massachusetts Special Commission on Public Health Effects of Xylazine released a report urging the state to expand low‑barrier treatment, tighten drug monitoring and launch coordinated education. Xylazine, an animal sedative, has risen from 5% to 26% of opioid‑related deaths...
CSL Ltd Slashes FY2026 Forecast, Flags $5 B Impairments as Shares Dive 20%
Interim CEO Gordon Naylor announced that CSL Ltd now expects FY2026 revenue of about $15.2 billion and underlying net profit of $3.1 billion, down from prior guidance. The company also disclosed roughly $5 billion in additional non‑cash impairments, triggering a 20% share plunge...
QP Essentials: Reducing Risk and Delays in EU and UK Trials
Clinical trial sponsors often encounter delays when shipping supplies to the EU and UK because Qualified Persons must certify each batch. Catalent’s webinar outlines the core QP responsibilities, highlights differences between EU and UK regulations, and offers practical steps such...
Chair File: Hospitals Integrate Behavioral Health Care, Provide Hope and Healing
The American Hospital Association (AHA) is amplifying its focus on behavioral health by outlining four strategic priorities: integration of physical and mental care, community partnerships, stigma reduction, and suicide prevention. The initiative coincides with Mental Health Awareness Month and National...
FDA Grants Fast Track Designation to Zai Lab’s DLL3-Targeting ADC for epNECs
Zai Lab’s DLL3‑targeting antibody‑drug conjugate zocilurtatug pelitecan received FDA Fast Track designation for extrapulmonary neuroendocrine carcinomas (epNECs). Early‑stage data showed a 38.2% objective response rate in heavily pre‑treated patients, indicating meaningful antitumor activity. The designation promises more frequent FDA interactions,...
NHS England’s Formal Recognition of Informatics Profession Brings CPD, Career Paths and Opportunity
NHS England and the Federation of Informatics Professionals (FedIP) have formalised a professional register for digital health and care staff, making membership mandatory for senior roles and rolling out to all DDaT employees by March 2031. The framework introduces compulsory...
Administrative Overload: The Mental Health Toll on Your Staff and Your Business
A new Edge survey finds that 76.4% of U.S. healthcare leaders consider administrative work overwhelming, and 75.5% say the burden has risen sharply over the past year. Hiring delays exacerbate the problem, with the average time to fill a healthcare...
Study Compares Two Antibiotics in Treating Severe Hemorrhagic Bacterial Pneumonia
Researchers at Osaka Metropolitan University compared cefiderocol (CFDC) and levofloxacin (LVFX) in a mouse model of severe hemorrhagic pneumonia caused by multidrug‑resistant Stenotrophomonas maltophilia. Both drugs significantly increased survival and reduced bacterial loads in lungs and heart relative to untreated...
Inside CSL’s Strategy to Simplify a Biotech Giant
CSL Limited is entering a strategic simplification phase, announced in August 2025, that will see its vaccine arm Seqirus spun off as a separate ASX‑listed company by the end of 2026 and a restructuring program that could cut up to 15% of...
Novo Nordisk microRNA Drug Fluffs Its Lines in Heart Failure
Novo Nordisk’s microRNA‑targeting drug CDR132L failed to demonstrate a statistically significant improvement in left ventricular end‑systolic volume index in the phase 2 HF‑REVERT trial. The study enrolled 280 post‑myocardial‑infarction patients with an ejection fraction of 45% or lower and elevated NT‑proBNP...
Swallowable Soft Robot Measures Stomach Acidity Without Endoscopy
A swallowable, electronics-free soft robot enables real-time stomach acidity measurement and fluid sampling, offering a less invasive alternative to endoscopy by gliding through the stomach and transmitting data via ultrasound. medicalinnovation
What the Six Hundred Billion Dollar MFN Headline Misses: The Best Price Carveout, the IQVIA Net Price Hole, and the...
The Council of Economic Advisers released a report projecting up to $600 billion in drug‑price savings over ten years, but the headline masks three critical flaws. First, the voluntary MFN agreements rely on the GENEROUS carve‑out that isolates supplemental rebates from...
Hantavirus Detected on Ship: Risk Remains Unclear
Why the "mildly" is irrelevant here: -we were simply watching for if any other passengers tested positive; not the viral load -the important part of the result is that *the test showed another passenger has hantavirus*. That means people still getting sick...
Providers Gain Upper Hand in No‑Surprises Arbitration Rule Talks
In the race to meet with regulators shaping forthcoming No Surprises Act arbitration rules, providers are winning https://t.co/QnV7scejZ2 via @statnews
Transforming Medical Coding Operations Through Hybrid Intelligence Design
Healthcare revenue cycle management faces rising coding volumes, evolving payer policies, and workforce shortages. AI improves efficiency for low‑complexity encounters but struggles with complex, multi‑specialty cases. A hybrid intelligence model blends AI‑driven coding with human‑in‑the‑loop review, routing high‑confidence cases to...
Beware Payer Panic; GLP‑1 Drugs Defy Bankruptcy Predictions
This is a reminder: when payers warn a new class of drugs will bankrupt a system, be cautious. We saw this with PCSK9 cholesterol meds, and then with Alzheimer's drugs. Unless of course that class of drugs begins with G and...
Rare Disease Community Gains New Treatment Hope After Five Years
Five years after disaster, a rare disease community gets new chance at treatment Yet another heart-rending story from @Jasonmmast. https://t.co/9vgOKpInL3
The Testes Are Highly Microvascularized: Acute COVID Can Damage the Testes, Long COVID-Spike Exposure May Slowly Damage Them Reducing Male...
Recent research highlights that the testes’ dense microvascular network makes them especially susceptible to damage from acute COVID‑19 infection and possibly lingering spike‑protein exposure. A 2024 ultrasound study of 875 men showed that higher ultrasonic microvascular density (UMVD) and testicular...
POD24 Signals Urgent Need for Wise Management
POD24 in follicular lymphoma: time to be “wise” [Mar 17, 2022] @JohnPLeonardMD @BloodJournal https://t.co/jLMd14D4Ur #lymsm https://t.co/991dNQe3JH
First‑line Lymphoma Therapies Linked to Higher Osteoporosis Risk
Increased risk of osteoporosis following commonly used first-line treatments for lymphoma: a Danish Nationwide Cohort Study [Feb 11, 2020] Baech et al. Leukemia & Lymphoma https://t.co/oapmDJlQV7 #lymsm #BoneHealth #SuppOnc #geriheme
The Gravity of Medical Insanity, and of Medical and Pharmaceutical Terrorism
The blog post denounces the Trump administration’s revision of the hepatitis B birth‑dose recommendation, alleging it will cause hundreds of infections and deaths. It accuses the FDA, CDC and Biden‑era officials of suppressing COVID‑19 vaccine safety data and frames these actions...
PET‑CT Can Opportunistically Assess Bone Density in Hodgkin Lymphoma
Opportunistic Evaluation of Bone Mineral Density by PET-CT in Hodgkin Lymphoma Patients [Jun 6, 2019] Cohen et al. Endocr Pract https://t.co/jdxVy80vMB #lymsm #supponc #oncorad #BoneHealth
Zoledronic Acid Prevents Bone Loss in Lymphoma Therapy
Zoledronic Acid for Prevention of Bone Loss in Patients Receiving Primary Therapy for Lymphomas: A Prospective, Randomized Controlled Phase III Trial [Dec 29, 2012] @Lymphoma_Doc @mtmdphd et al. CLML https://t.co/iPOYSXEA1M #lymsm #SuppOnc #BoneHealth #NCT00352846 https://t.co/UlaqHyy65d
Mild Animal Skin Disease Detected in MSM, No Livestock Contact
Doctors in several European cities are seeing cases of an animal skin disease in men who have sex with men who haven't had contact with the livestock that normally contract this disease. The good news is, it's mild & treatable....